• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫肌切除术前行GnRHa的临床应用:20例报告

[Clinical application of GnRHa before uterine myomectomy: report of 20 cases].

作者信息

Yu Yan-hong, Gong Shi-peng, Wan Shu-mei

机构信息

Department of Obstetrics and Gynecology, Nanfang Hospital, First Military Medical University, Guangzhou 510515, China.

出版信息

Di Yi Jun Yi Da Xue Xue Bao. 2004 Mar;24(3):317-9.

PMID:15041550
Abstract

OBJECTIVE

To study the clinical application of GnRHa prior to uterine myomectomy and its effect on the clinical outcome of pregnancy.

METHODS

A retrospective review of the medical records in 20 cases of uterine myomectomy over a period of 6 years was performed. The changes of uterus and myoma volumes in response to preoperative GnRHa was observed, and the rate of relapse in the follow-up, time of impregnation, spontaneous abortion after the impregnation, time of delivery after the operation and the aura threatening uterine rupture, and uterine rupture during the delivery were assessed.

RESULTS

Application of GnRHa produced significant improvement in the clinical symptoms and resulted in obviously reduced volumes of the uterus and myoma. The myoma volume reduction was close to 50% in these cases, and relapse occurred in only 1 case. No spontaneous abortion was found after GnRHa application. The average time of pregnancy was 34+/-3.5 weeks, and aura for uterine rupture was found in 1 case at 33 weeks of pregnancy after GnRHa application.

CONCLUSION

Application of GnRHa can correct anemia, decrease the relapse rate of myoma, reduce uterus and myoma volumes, to make possible smaller incision for uterine myomectomy that leaves smaller scar in the uterus and decrease intraoperative bleeding, also relieving endometrial injuries to promote the conditions for impregnation and minimize the risks of uterine rupture and total hysterectomy for the benefit of normal delivery.

摘要

目的

研究促性腺激素释放激素激动剂(GnRHa)在子宫肌瘤切除术术前的临床应用及其对妊娠临床结局的影响。

方法

回顾性分析6年间20例行子宫肌瘤切除术患者的病历资料。观察术前应用GnRHa后子宫及肌瘤体积的变化,并评估随访中的复发率、受孕时间、受孕后的自然流产情况、术后分娩时间以及分娩时子宫破裂先兆和子宫破裂情况。

结果

应用GnRHa后临床症状有显著改善,子宫和肌瘤体积明显缩小。这些病例中肌瘤体积缩小近50%,仅1例复发。应用GnRHa后未发现自然流产情况。平均妊娠时间为34±3.5周,应用GnRHa后1例在妊娠33周时出现子宫破裂先兆。

结论

应用GnRHa可纠正贫血,降低肌瘤复发率,缩小子宫和肌瘤体积,使子宫肌瘤切除术切口更小,子宫瘢痕更小,减少术中出血,减轻子宫内膜损伤,改善受孕条件,降低子宫破裂和全子宫切除的风险,有利于正常分娩。

相似文献

1
[Clinical application of GnRHa before uterine myomectomy: report of 20 cases].子宫肌切除术前行GnRHa的临床应用:20例报告
Di Yi Jun Yi Da Xue Xue Bao. 2004 Mar;24(3):317-9.
2
A comparison of combined laparoscopic uterine artery ligation and myomectomy versus laparoscopic myomectomy in treatment of symptomatic myoma.腹腔镜下子宫动脉结扎联合子宫肌瘤剔除术与单纯腹腔镜子宫肌瘤剔除术治疗症状性子宫肌瘤的比较
Fertil Steril. 2009 Aug;92(2):742-7. doi: 10.1016/j.fertnstert.2008.06.011. Epub 2008 Aug 9.
3
Pregnancy and delivery after laparoscopic myomectomy.腹腔镜子宫肌瘤切除术后的妊娠与分娩
J Minim Invasive Gynecol. 2005 May-Jun;12(3):241-6. doi: 10.1016/j.jmig.2005.03.011.
4
Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.地诺孕素对子宫肌瘤体积的有益影响:一项与促性腺激素释放激素激动剂比较的回顾性对照研究。
Arch Gynecol Obstet. 2011 Sep;284(3):667-70. doi: 10.1007/s00404-010-1732-6. Epub 2010 Oct 30.
5
Italian multicenter study on complications of laparoscopic myomectomy.意大利关于腹腔镜子宫肌瘤切除术并发症的多中心研究。
J Minim Invasive Gynecol. 2007 Jul-Aug;14(4):453-62. doi: 10.1016/j.jmig.2007.01.013.
6
Spontaneous uterine rupture in the early third trimester after laparoscopically assisted myomectomy. A case report.腹腔镜辅助子宫肌瘤切除术后妊娠晚期自发性子宫破裂。病例报告。
J Reprod Med. 2000 Feb;45(2):139-41.
7
A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
Obstet Gynecol. 1989 Dec;74(6):856-62.
8
Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy.促性腺激素释放激素激动剂治疗后子宫内膜异位症、子宫腺肌病和子宫肌瘤组织炎症、血管生成和细胞凋亡的变化。
Hum Reprod. 2010 Mar;25(3):642-53. doi: 10.1093/humrep/dep437. Epub 2009 Dec 15.
9
Hormonal therapy before surgical treatment for uterine leiomyomas.
Surg Gynecol Obstet. 1991 Jun;172(6):497-502.
10
Predictors of leiomyoma recurrence after laparoscopic myomectomy.腹腔镜子宫肌瘤切除术后肌瘤复发的预测因素
J Minim Invasive Gynecol. 2007 Nov-Dec;14(6):690-7. doi: 10.1016/j.jmig.2007.06.003.

引用本文的文献

1
Comparing the Use of Uterine Artery Embolization to Gonadotropin-Releasing Hormone Agonists in Shrinking Fibroid Size: A Pilot Study in Kazakhstan.比较子宫动脉栓塞术与促性腺激素释放激素激动剂在缩小肌瘤大小方面的应用:哈萨克斯坦的一项试点研究。
Cent Asian J Glob Health. 2015 Sep 17;4(1):232. doi: 10.5195/cajgh.2015.232. eCollection 2015.